0.513
-0.04 (-7.66%)
| Penutupan Terdahulu | 0.555 |
| Buka | 0.535 |
| Jumlah Dagangan | 563,748 |
| Purata Dagangan (3B) | 1,751,832 |
| Modal Pasaran | 15,574,176 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.61 |
| Harga / Jualan (P/S) | 0.330 |
| Harga / Buku (P/B) | 34.84 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Nov 2025 |
| Margin Keuntungan | -4.30% |
| Margin Operasi (TTM) | -49.28% |
| EPS Cair (TTM) | -0.240 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -42.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -33.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 351.59% |
| Nisbah Semasa (MRQ) | 3.46 |
| Aliran Tunai Operasi (OCF TTM) | 12.72 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 7.68 M |
| Pulangan Atas Aset (ROA TTM) | -4.11% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Distribution (US) | Bercampur | Bercampur |
| Medical Distribution (Global) | Bercampur | Menaik | |
| Stok | Zynex, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.38 |
|
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others. |
|
| Sektor | Healthcare |
| Industri | Medical Distribution |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 48.37% |
| % Dimiliki oleh Institusi | 22.92% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Nov 2025 | Pengumuman | Zynex Reports Third Quarter 2025 Financial Results |
| 14 Nov 2025 | Pengumuman | Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee |
| 14 Nov 2025 | Pengumuman | Zynex Sets Third Quarter 2025 Earnings Call |
| 14 Oct 2025 | Pengumuman | Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |